Stay informed with the latest updates from Alkan Chemical Europe.
From industry exhibitions to market insights and product launches, this is where we share what’s new, what’s next, and where you can meet us.
Keep up with our announcements and business milestones, including:
• New product launches and portfolio expansions
• Strategic supplier partnerships and territory authorizations
• Regulatory updates and documentation improvements
• Investments in digitalization, compliance, and service capabilities
We regularly post updates relevant to our customers, suppliers, and regulatory partners across Europe, the Middle East, and North Africa.
Alkan Chemical Europe participates in key international trade fairs and regional events to connect with partners, discover innovations, and promote our growing product portfolio.
Meet us at upcoming events such as:
• CPHI Worldwide
• Maghreb Pharma Expo
• CPHI Middle East
• Select national conferences and industry forums
We invite you to schedule a meeting with our team in advance or visit our booth to learn how we can support your sourcing, compliance, and market access needs.
In 2025, Alkan Chemical Europe proudly celebrates its 15th anniversary. Since our establishment in Düsseldorf, we have evolved into a reliable distribution partner for pharmaceutical raw materials, supporting manufacturers across Europe, the Middle East, and North Africa. This milestone provides an opportunity to reflect on our journey, highlight what makes us a trusted partner, and share our vision for the years ahead.
Alkan Chemical Europe will exhibit at CPHI Frankfurt 2025, bringing our portfolio of APIs, excipients, and specialty chemicals to the heart of Europe’s largest pharmaceutical marketplace. As we celebrate 15 years of service to formulation and procurement teams across EMEA, this exhibition is a prime opportunity to strengthen partnerships, discuss second-supplier strategies, and explore cost-efficient, compliant solutions that scale.
Pharmaceutical supply chains in Europe and MENA face persistent pressure from price volatility, single-origin dependencies, and evolving regulatory expectations. A structured second-supplier strategy is no longer a “nice to have”. It is a board-level capability that protects continuity of supply, stabilizes total cost, and shortens recovery time when disruptions occur. Regulators reinforce this direction by promoting quality risk management, proactive shortage prevention, and stronger supplier oversight.
Pharmaceutical excipients are often described as “inactive ingredients,” yet they are anything but secondary in the development of modern medicines. Excipients form the foundation of dosage forms, enabling APIs to be delivered safely, effectively, and in a way that patients can tolerate. Without them, most medicines would remain unstable, non-scalable, or clinically ineffective.
Follow us on LinkedIn for real-time updates, product highlights, and event coverage.
You can also subscribe to our quarterly newsletter (coming soon) for curated insights and partner news.